BMI does not capture the high fat mass index and low fat-free mass index in children with cerebral palsy and proposed statistical models that improve this accuracy.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
01 2019
Historique:
received: 15 09 2017
accepted: 19 06 2018
revised: 22 04 2018
pubmed: 6 9 2018
medline: 6 2 2020
entrez: 6 9 2018
Statut: ppublish

Résumé

Children with cerebral palsy (CP) are at risk for having a misclassified overweight/obesity status based on BMI thresholds due to their lower fat-free mass and similar fat mass compared with typically developing children. The primary objective was to determine if BMI could predict fat mass index (FMI) and fat-free mass index (FFMI) in children with CP. Forty-two children with CP and 42 typically developing children matched to children with CP for age and sex participated in the study. Dual-energy X-ray absorptiometry was used to assess body composition. Children with CP who could ambulate without assistance were considered ambulatory (ACP) and the rest were considered nonambulatory (NACP). Children with CP had higher percent body fat (%Fat) and FMI and lower fat-free mass and FFMI than controls (p < 0.05) but no difference in fat mass (p = 0.10). When BMI was statistically controlled, NACP had higher %Fat, fat mass and FMI and lower FFMI than ACP and controls (p < 0.05). NACP also had lower fat-free mass than controls (p < 0.05). ACP had higher %Fat and FMI and lower fat-free mass and FFMI than controls (p < 0.05). BMI was a strong predictor of FMI (r Compared with typically developing children, children with CP have a higher FMI and lower FFMI for a given BMI, which is more pronounced in NACP than ACP. The finding suggests that the prevalence of overweight/obesity status may be underestimated in children with CP.

Sections du résumé

BACKGROUND/OBJECTIVES
Children with cerebral palsy (CP) are at risk for having a misclassified overweight/obesity status based on BMI thresholds due to their lower fat-free mass and similar fat mass compared with typically developing children. The primary objective was to determine if BMI could predict fat mass index (FMI) and fat-free mass index (FFMI) in children with CP.
SUBJECTS/METHODS
Forty-two children with CP and 42 typically developing children matched to children with CP for age and sex participated in the study. Dual-energy X-ray absorptiometry was used to assess body composition. Children with CP who could ambulate without assistance were considered ambulatory (ACP) and the rest were considered nonambulatory (NACP).
RESULTS
Children with CP had higher percent body fat (%Fat) and FMI and lower fat-free mass and FFMI than controls (p < 0.05) but no difference in fat mass (p = 0.10). When BMI was statistically controlled, NACP had higher %Fat, fat mass and FMI and lower FFMI than ACP and controls (p < 0.05). NACP also had lower fat-free mass than controls (p < 0.05). ACP had higher %Fat and FMI and lower fat-free mass and FFMI than controls (p < 0.05). BMI was a strong predictor of FMI (r
CONCLUSION
Compared with typically developing children, children with CP have a higher FMI and lower FFMI for a given BMI, which is more pronounced in NACP than ACP. The finding suggests that the prevalence of overweight/obesity status may be underestimated in children with CP.

Identifiants

pubmed: 30181652
doi: 10.1038/s41366-018-0183-1
pii: 10.1038/s41366-018-0183-1
pmc: PMC8007077
mid: NIHMS976887
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-90

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD090126
Pays : United States
Organisme : NICHD NIH HHS
ID : R03 HD050530
Pays : United States
Organisme : NICHD NIH HHS
ID : R15 HD071397
Pays : United States

Références

Arch Pediatr Adolesc Med. 1995 Jun;149(6):658-62
pubmed: 7767422
Am J Clin Nutr. 1996 Oct;64(4):627-34
pubmed: 8839510
Dev Med Child Neurol. 2005 Feb;47(2):77-85
pubmed: 15707230
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):579-86
pubmed: 12653524
Arch Phys Med Rehabil. 2014 Aug;95(8):1540-6
pubmed: 24742941
Int J Obes (Lond). 2005 Jan;29(1):1-8
pubmed: 15278104
Am J Clin Nutr. 2013 Nov;98(5):1367
pubmed: 24142239
J Intellect Disabil Res. 2010 Sep;54(9):787-94
pubmed: 20630017
Dev Med Child Neurol. 2000 May;42(5):292-6
pubmed: 10855648
Osteoporos Int. 2009 Apr;20(4):609-15
pubmed: 18763012
J Clin Endocrinol Metab. 2014 Sep;99(9):3208-16
pubmed: 24926951
Mayo Clin Proc. 2016 Apr;91(4):443-55
pubmed: 26948431
Am J Clin Nutr. 1990 Dec;52(6):953-9
pubmed: 2239792
Arch Dis Child. 2001 Jul;85(1):67-72
pubmed: 11420208
Int J Obes Relat Metab Disord. 2002 Oct;26(10):1323-8
pubmed: 12355328
J Paediatr Child Health. 2016 Apr;52(4):417-21
pubmed: 27145505
J Bone Joint Surg Am. 2007 Nov;89(11):2421-6
pubmed: 17974884
J Nutr. 2010 Dec;140(12):2260-5
pubmed: 20980659
Bone. 2017 Jan;94:90-97
pubmed: 27732905
Am J Phys Med Rehabil. 2008 May;87(5):395-403
pubmed: 18174849
Dev Med Child Neurol. 1999 Sep;41(9):580-5
pubmed: 10503915
J Clin Endocrinol Metab. 2017 Jan 1;102(1):185-194
pubmed: 27802095
Am J Clin Nutr. 1996 Nov;64(5):669-76
pubmed: 8901784
BMC Pediatr. 2013 Jun 24;13:99
pubmed: 23799991
J Pediatr. 2011 Oct;159(4):691-4.e2
pubmed: 21802095
J Pediatr. 1995 May;126(5 Pt 1):833-9
pubmed: 7752019
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
Am J Clin Nutr. 2013 Nov;98(5):1368-9
pubmed: 24142240
J Pediatr. 2009 May;154(5):715-20
pubmed: 19111321
Clin Nutr. 2015 Feb;34(1):140-5
pubmed: 24613145
Am J Clin Nutr. 2010 Aug;92(2):313-9
pubmed: 20534743
Am J Clin Nutr. 2017 Feb;105(2):369-378
pubmed: 28077375
Am J Med. 2017 Jun;130(6):744.e9-744.e15
pubmed: 28065772
Dev Med Child Neurol. 1992 Jan;34(1):55-60
pubmed: 1544515
Dev Med Child Neurol. 2015 Sep;57(9):858-64
pubmed: 25827868
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581

Auteurs

Daniel G Whitney (DG)

Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.

Freeman Miller (F)

Department of Orthopedics, Nemours AI duPont Hospital for Children, Wilmington, DE, USA.

Ryan T Pohlig (RT)

Biostatistics Core Facility, University of Delaware, Newark, DE, USA.

Christopher M Modlesky (CM)

Department of Kinesiology, University of Georgia, Athens, GA, USA. christopher.modlesky@uga.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH